瑞普生物

- 300119

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015 
瑞普生物(300119) 利润表
单位:万元
报表日期2025-03-312024-12-312024-09-302024-06-302024-03-31
一、营业总收入82,161.65306,993.31174,680.64109,903.8153,319.91
营业收入82,161.65306,993.31174,680.64109,903.8153,319.91
二、营业总成本69,487.49269,014.04146,682.1693,026.4943,586.77
营业成本48,289.83179,972.2688,400.8756,579.4227,872.85
营业税金及附加583.202,634.651,677.061,158.74417.99
销售费用10,037.6645,138.3128,779.0018,018.347,128.53
管理费用4,905.4818,894.4312,496.937,886.854,018.24
财务费用877.242,720.621,812.031,034.93507.26
研发费用4,794.0819,653.7713,516.278,348.203,641.89
资产减值损失----------
公允价值变动收益2,532.87-1,070.782,348.601,489.181,017.95
投资收益-70.11914.28158.01164.363.10
其中:对联营企业和合营企业的投资收益-79.26379.44142.90151.82-8.86
汇兑收益----------
三、营业利润13,734.0437,316.8030,407.9218,907.9910,537.54
加:营业外收入22.19159.80130.58103.3636.97
减:营业外支出213.02647.68309.61180.3466.67
其中:非流动资产处置损失----------
四、利润总额13,543.2236,828.9130,228.8918,831.0210,507.85
减:所得税费用1,532.743,845.523,810.612,050.171,157.38
五、净利润12,010.4832,983.3926,418.2716,780.859,350.47
归属于母公司所有者的净利润11,598.4730,072.2324,473.6515,913.948,757.11
少数股东损益412.012,911.161,944.62866.91593.36
六、每股收益
基本每股收益(元/股)0.25490.65330.53130.34560.1901
稀释每股收益(元/股)0.25490.65330.53130.34560.1901
七、其他综合收益----------
八、综合收益总额12,010.4832,983.3926,418.2716,780.859,350.47
归属于母公司所有者的综合收益总额11,598.4730,072.2324,473.6515,913.948,757.11
归属于少数股东的综合收益总额412.012,911.161,944.62866.91593.36
下载全部历史数据到excel中 返回页顶